Voya Financial (VOYA) Q3 Earnings and Revenues Top Estimates


Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, January 4th:

United Therapeutics UTHR: This company which is engaged in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally, has a Zacks Rank #1(Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.

United Therapeutics Corporation Price and Consensus

United Therapeutics Corporation price-consensus-chart | United Therapeutics Corporation Quote

United Therapeutics’s shares gained 26.7% over the last three month compared with the S&P 500’s gain of 0.1%. The company possesses a Momentum Score of A.

United Therapeutics Corporation Price

United Therapeutics Corporation Price

United Therapeutics Corporation price | United Therapeutics Corporation Quote

Casey’s General Stores CASY: This convenience stores which offer a variety of food selection in 16 Midwestern states, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.0% over the last 60 days.

Casey’s General Stores, Inc. Price and Consensus

Casey's General Stores, Inc. Price and Consensus

Casey’s General Stores, Inc. price-consensus-chart | Casey’s General Stores, Inc. Quote

Casey’s General Stores’s shares gained 8.7% over the last three month compared with the S&P 500’s gain of 0.1%. The company possesses a Momentum Score of B.

Casey’s General Stores, Inc. Price

Casey's General Stores, Inc. Price

Casey’s General Stores, Inc. price | Casey’s General Stores, Inc. Quote

 

See the full list of top ranked stocks here

 

Learn more about the Momentum score and how it is calculated here.

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

United Therapeutics Corporation (UTHR) : Free Stock Analysis Report

Casey’s General Stores, Inc. (CASY) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



Image and article originally from www.nasdaq.com. Read the original article here.

By Zacks